News, Articles and more

Dresden, Germany

Image-based explainable AI accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia

Cytomorphologic analysis of the bone marrow is crucial for the initial diagnosis of myelodysplastic neoplasms (MDS), yet the accurate identification of dysplastic features is often challenging, time-consuming, and prone to…
Dresden, Germany

Generating reliable synthetic clinical trial data

A must-read for everyone working with or interested in synthetic clinical trial data. This work, part of Waldemar Hahn’s PhD project, shows that compound-metric hyperparameter optimization (HPO), together with robust…
Düsseldorf, Germany

MEDICA Lab Forum 2025

AI-driven diagnostics is no longer a future vision — it is already transforming laboratory medicine. Moritz was invited to give a talk on AI-based laboratory diagnostics in hematooncology at the…
Dresden, Germany

AI for risk assessment and outcome prediction in malignant haematology

Artificial Intelligence is reshaping risk prediction and personalized treatments in hematology. In our new review now published in the British Journal of Haematology, we provide a comprehensive overview of machine…
Dresden, Germany

Differential prognostic impact of myelodysplasia-related gene mutations in AML

Myelodysplasia-related gene mutations (MRG) have received a lot of attention in recent updates on AML classification and prognosis. Yet, individual MRGs are rare and often lumped together as a single…
Busan, Korea

ICBMT 2025

Jan was invited to speak at the ICBMT 2025 in Busan, hosted by the Korean Society of Bone Marrow Transplantation, on the transformative potential of AI in hematology. It was…
Dresden, Germany

Promises and challenges of AI in haematological diagnostics

Artificial intelligence is set to revolutionize medicine, but its implementation is not without challenges. Bias mitigation, seamless integration into diagnostic and clinical workflows, and AI literacy for clinicians is essential.…
Dresden, Germany

AML diagnostics in the 21st century: Use of AI

We are excited to share our latest invited review article – the product of an amazing collaboration with our dear colleagues from the MLL Münchner Leukämielabor led by Prof. Dr.…
Milan, Italy

EHA 2025

The annual meeting of the European Hematology Association (EHA) has been a blast! Jan was invited to give a Spotlight Talk on Artificial Intelligence in Hematological Diagnostics, exploring and discussing…
Heidelberg, Germany

4th German Cancer Research Congress

Jan presented our work „Age-Stratified Machine Learning Identifies Divergent Prognostic Significance of Molecular Alterations in AML” as a poster presentation at the 4th German Cancer Research Congress in Heidelberg. We are…
Dresden, Germany

Towards Accurate Risk Prediction in Leukemia

Precision medicine aims to deliver the right therapy to the right patient, but our current models of risk stratification are often too simplistic to meet that goal. Many models treat…
Hamburg, Germany

New Impulses for Cancer Treatments with AstraZeneca

We had a great time discussing new avenues for cancer management with AstraZeneca, including synthetic data generation for the next generation of clinical trials. Check out the podcast at AstraZeneca’s…
Dresden, Germany

Synthetic Microscopy Image Data Augments Leukemia Detection Models

Innumerable medical images are generated in routine diagnostics every day, but only a tiny fraction of them is accessible to train machine learning models. Oftentimes, privacy concerns are cited as…
San Diego, USA

ASH 2024

Our research group had a tremendously successful time at this year’s meeting of the American Society of Hematology 🎤 one oral presentation 📜 five poster presentations 🥇 four abstract achievement…
Dresden, Germany

See you in San Diego! #ASH2024

We are happy to announce that our group will be joining the annual meeting of the American Society of Hematology in San Diego with six accepted abstracts! #1057: Synthetic Bone…
Dresden, Germany

Our team has won the „Digital Laboratory Award“ by the German Society of Laboratory Medicine!

We are thrilled to announce that Moritz Middeke and Jan Eckardt received the “Digital Laboratory Award” of the German Society of Laboratory Medicine 🎉 They were honored for their research…
Dresden, Germany

Inspiring HemAI Workshop with Janssen

At our recent HemAI Workshop in Dresden, a joint initiative between our working group and Janssen, we delved into the promising field of AI in hematology. The sessions were filled…
Dresden, Germany

Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence

Clinical trials become increasingly more expensive and time-consuming. High failure rates especially in late phase trials put a substantial financial burden on healthcare systems and pharmaceutical companies. Hence, a paradigm…
San Diego, USA

AI at ASH!

Welcomed by the warm San Diego sun, we embarked on a week filled with exciting research and innovations in hematology at this year’s annual meeting of the American Society of…
New York City

Grand Rounds in New York City

We were pretty busy with invited talks in autumn! Jan was invited as a Grand Rounds speaker at the Tisch Cancer Institute at Mount Sinai Hospital in New York. The…